GWP
WST icon

Gen-Wealth Partners’s West Pharmaceutical WST Stock Holding History

Gen-Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Buy
1,269
+48
+4% +$11.9K 0.1% 189
2025
Q4 		$336K Sell
1,221
-681
-36% -$186K 0.11% 199
2025
Q3 		$499K Sell
1,902
-8
-0.4% -$1.94K 0.17% 147
2025
Q2 		$418K Sell
1,910
-43
-2% -$9.19K 0.16% 151
2025
Q1 		$437K Buy
1,953
+77
+4% +$21.2K 0.18% 146
2024
Q4 		$614K Buy
1,876
+31
+2% +$9.76K 0.26% 95
2024
Q3 		$578K Buy
1,845
+615
+50% +$188K 0.25% 105
2024
Q2 		$405K Buy
1,230
+131
+12% +$46.3K 0.2% 129
2024
Q1 		$435K Buy
+1,099
New +$407K 0.22% 125

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return